Ann Mullally

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 9

Top Topics

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi Mark Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew Joseph Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Jonas Samuel Jutzi, Anna E Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W Dressman, Hongyan Liang, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fátima Al-Shahrour, Ann Mullally
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood 140 (11) (2022)
Jonas Samuel Jutzi, Anna E Marneth, María José Jiménez-Santos, Jessica Hem, Angel Guerra-Moreno, Benjamin Rolles, Shruti Bhatt, Samuel A Myers, Steven A Carr, Yuning Hong, Olga Pozdnyakova, Peter van Galen, Fátima Al-Shahrour, Anna S Nam, Ann Mullally
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response. Leukemia (2022)
Baransel Kamaz, Ann Mullally
COVID-19 and myeloproliferative neoplasms: some considerations. Leukemia 35 (1) (2020)
Adam J Mead, Ann Mullally
Myeloproliferative neoplasm stem cells. Blood 129 (12) (2017)
Steven W Lane, Ann Mullally
Hit the spleen, JAK! Blood 124 (19) (2015)
Edwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, Emily A Rosen, Luke Poveromo, Shannon Elf, Amy Ko, Kristina Brumme, Ross Levine, Benjamin L Ebert, Ann Mullally
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood 125 (2) (2014)